PCF

Switch ETFs

00897 Fubon Global Genomics and Immuno Biopharma ETF
  • Portfolio Composition File
  • 2026/11/23
  • The Amount of Total Advance Subscription

    NT$7,230,000

  • Net Asset Value(NAV)

    NT$1,528,326,442

  • Total Units Outstanding

    116,512,000

  • Net Unit Change

    0

  • NAV Per Unit

    NT$13.12

  • Creation/Redemption Unit

    500,000

  • Equity Value Per Basket

    NT$6,558,665

  • Cash Component Per Basket

    NT$-776,497

  • Price per creation basket

    NT$6,573,503

  • Estimated units outstanding

    116,512,000

Primary Market

Fund Purchase

Yes

Fund Redemption

Yes

Total Beneficiaries (2026/10)

9,544

每申購基數實際申購總價金及總價金差異額與實際執行結果有關,以基金經理公司通知給付之金額為準,詳請參閱公開說明書。
  • Domestic ETF
  • Overseas ETF
  • Leveraged / Inverse ETF
  • Fixed Income ETF
  • Actively Managed ETF